Understood reports that the FDA has approved Simtriyo, a new ADHD medication targeting dopamine, norepinephrine, and serotonin, promising fewer side effects.

A new study led by the University of Southampton has found that medications for ADHD have overall small effects on blood pressure and heart rate after weeks or a few months of use. There have been ...

Simtriyo was just approved by the U.S. Food and Drug Administration to treat attention-deficit/hyperactivity disorder (ADHD) in children, teens, and adults. The ADHD ...

Once believed to be a condition that children outgrow, attention deficit hyperactivity disorder (ADHD) is now recognized as a ...

These side effects included hallucinations, delusions, hearing voices, and/or perceptual disturbances, the researchers said. By comparison, psychotic effects affected just over one-quarter of those ...

Add Yahoo as a preferred source to see more of our stories on Google. In recent years, kratom has gained significant attention for its potential therapeutic benefits, including its use in managing ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. As ...

Azstarys can cause certain side effects, some of which are more common than others. These side effects may be temporary, lasting a few days to weeks. However, if the side effects last longer than that ...

The FDA has approved Otsuka Pharmaceutical’s once-daily extended-release capsule Simtriyo (centanafadine) f | Approval of the ...

Experts say the rise has been fuelled by the 'medicalisation of distress' and warn behaviours once considered normal are now ...

A head-to-head trial of ADHD treatments finds dexamphetamine and methylphenidate equally effective, with notable differences ...